Cambridge, United Kingdom

I-Jen Chen

USPTO Granted Patents = 27 

 

 

Average Co-Inventor Count = 10.4

ph-index = 4

Forward Citations = 44(Granted Patents)


Location History:

  • Winnersh, GB (2016 - 2017)
  • Cambridge, GB (2015 - 2023)

Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: Innovator Profile: I-Jen Chen

Introduction: I-Jen Chen is a distinguished inventor based in Cambridge, GB, known for his significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 27 patents, he has developed innovative compounds that hold promise for the treatment of various diseases, including cancer.

Latest Patents: Among his latest patents are groundbreaking inventions such as "Macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same" and "Pyrrole compounds, a process for their preparation and pharmaceutical." These patents detail compounds that are instrumental in the manufacture of medicaments, particularly those targeting pathologies involving a deficit in apoptosis, such as cancer and autoimmune diseases.

Career Highlights: I-Jen Chen has an impressive career history, including significant roles in research and development at various renowned companies. He has contributed to the innovative projects at Vernalis Limited and Les Laboratoires Servier, where he focused on advancing pharmaceutical research.

Collaborations: Throughout his career, I-Jen has collaborated with notable professionals, including James Edward Paul Davidson and James Brooke Murray. These collaborations have further enhanced his research and development efforts, leading to the successful creation of medicinal compounds.

Conclusion: I-Jen Chen’s pioneering work in medicinal chemistry is evident from his extensive patent portfolio and his collaborations in the industry. His innovative contributions continue to influence the development of effective treatments for complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…